Alan Brochstein, CFA, was the first investment professional to devote himself to sharing his observations about the cannabis industry from an investor's perspective publicly. He runs 420 Investor, a subscription-based due diligence platform for investors interested in the publicly-traded cannabis stocks and is also the founder of New Cannabis Ventures, a content aggregation site focused on investors and entrepreneurs in the cannabis industry. Alan has worked in the securities industry since 1986, primarily with the responsibility for managing investments in institutional environments until he founded AB Analytical Services in 2007 in order to provide independent research and consulting to registered investment advisors. In addition to advising several different hedge funds and investment managers, including Friedberg Investment Management, where he participated as a member of its investment management committee, Alan was also a senior analyst for the independent research firm Management CV. In 2008, he began providing a first-of-its-kind subscription-based service for individual investors, Invest By Model, which offered two different portfolios that investors could replicate in their own accounts. Alan also offered The Analytical Trader at Marketfy, where he used fundamental and technical analysis in a disciplined process to offer specific trade ideas geared towards swing traders. Alan launched www.420Investor.com in late 2013 as the premier source of information for "Green Rush" investors seeking to capitalize on the proliferation of legalized medical and recreational cannabis. In March 2014, Alan, who is a member of the National Cannabis Industry Association, began to focus solely on the cannabis sector. He launched www.NewCannabisVentures.com in late 2015. You can follow Alan on Facebook (www.facebook.com/420investor) or on Twitter (https://twitter.com/Invest420). Alan also moderates a large LinkedIn group focused on the cannabis industry, Cannabis Investors & Entrepreneurs (https://www.linkedin.com/groups/6523904)
Welcome. My name is Jeff Khoshaba and I am an entrepreneur-turned-analyst. I write about equities and real estate, with a focus on the legal cannabis sector. I also write financial research articles for The Deep Dive. All opinions expressed are my own.
Founded by Nate Anderson, CFA, CAIA, Hindenburg Investment Research specializes in forensic research and activist short-selling. Our experience in the investment management industry spans over a decade, with a historical focus on buy side equity, credit, and derivatives analysis.
While we use fundamental analysis to aid our investment decision-making, we believe the best edge can be had by uncovering hard-to-find information from atypical sources. In particular we look for situations where companies may have any combination of (i) accounting irregularities (ii) bad actors in management or key service provider roles (iii) undisclosed related-party transactions (iv) or illegal/unethical business or financial reporting practices.
Tips and feedback can be sent to firstname.lastname@example.org
Sharesleuth.com is an investigative business reporting site backed by entrepreneur Mark Cuban. Sharesleuth seeks to expose companies and individuals engaged in securities fraud and other activities that tend to deceive investors. Chris Carey, editor of Sharesleuth, previously was an award-winning business reporter at the St. Louis Post-Disptach, the Indianapolis Star, and the Orlando Sentinel. He began his career at the Messenger-Inquirer in Owensboro, Ky. He graduated from Indiana University with a double major in journalism and economics.
We are the expert in cannabis with coverage on a broad range of cannabis topics and over 20 companies in the global cannabis industry. Our Weekly Cannabis Report is the go-to for investors looking to invest in the cannabis sector. Our proprietary research and straightforward writing style have helped readers make better investment decisions. Join the green conversation by following us.
Former financial analyst - CFA (inactive), portfolio manager and research director with over forty years of investment experience. Media credentials/experience includes daily radio commentaries, weekly newspaper columnist and Internet video host. Also a published business/financial markets author.
Michael Berger is the president and founder of Technical420, an research firm focused specifically on the cannabis sector. Prior to starting Technical420, Mr. Berger was working for the Equity Research department at Raymond James Financial Inc. While at Raymond James, Mr. Berger also worked as a Financial Analyst for the Private Client Group and as a Compliance Advisor for the Compliance department. Mr. Berger studied finance and economics at Florida State University.
Wall Street Breakfast, Seeking Alpha's flagship daily business news summary, is a one-page summary that gives you a rapid overview of the day's key financial news. It's designed for easy readability on the site or by email (including on mobile devices), and is published before 7:00 AM ET every market day.
Wall Street Breakfast readership of over 900,000 includes many from the investment-banking and fund-management industries.
Sign up here to receive the Wall Street Breakfast in your inbox every business day: http://seekingalpha.com/account/email_preferences
Roddy Boyd is an investigative reporter who has worked for Fortune Magazine, the New York Post, The New York Sun and Institutional Investor News. He also founded The Financial Investigator website, www.thefinancialinvestigator.com. I also wrote "Fatal Risk," on the collapse of AIG.
Most recently, he has founded the Southern Investigative Reporting Foundation, www.sirf-online.org.
SIRF is dedicated to providing document-driven investigative reporting on publicly traded companies. Our work is centered on providing accountability and information to the investing public and regulators. We are organized as a tax-exempt organization, are members of the Investigative News Network and gladly adhere to the highest standards of journalistic integrity. We do not invest in any securities, short or long, and do not take payment for our work. No one sees our work prior to publication.
Dallas currently owns and operates as CEO an Austin-based enterprise consulting firm that specializes in private company lifecycle management, up to and including taking companies public, and in helping consult publicly traded companies ranging in market cap from $100 million to $500 million. He has a specialization in deal flow management and is often the referring and closing source of Joint Ventures and broader M&A. Dallas often works directly with management teams and Boards of microcap and stressed equity companies in which he or members of his professional network are heavily invested. This includes helping with overall strategy, helping with capital structure management, helping facilitate liquidity, helping facilitate Joint Ventures and broader M&A, and helping restructure the business segments if necessary. Recently Dallas has been interviewed by The Pittsburgh Business Times, The Banker, Columbus Business First, Houston Business Journal, The Deal, Energy Intelligence, and his tweets have been used by CNBC to highlight hot button issues regarding Carl Icahn, Bill Ackman, Nelson Peltz’s takeover attempts at DuPont, etc. Dallas has also been quoted and sourced to by StreetSweeper.org, Marcellus.com, MarcellusDrilling.com, Bakken.com, OilOnline.com, and other physical and online publications. "One place of great inefficiency is in the stressed equity markets – or the markets in which a company appears as bankruptcy or a breakup is inevitable. As equities become stressed they often sell down to absurd levels of value that present, should there be value to be unlocked, opportunities for “venture level” returns."
Debra Borchardt is a former Vice President of Bear Stearns where she worked for 15 years before its demise. She held a Series 7 and RIA license. She left Wall Street after getting her Masters degree in Business Journalism from New York University to become a financial reporter. Since then, Debra worked at TheStreet.com for eight years and recently launched the financial cannabis news website Green Market Report. She has covered the cannabis industry for over 5 years and is in demand as a moderator at many cannabis conferences due to her knowledge about the sector.
Author of INTRODUCTIION TO FINANCIAL ACCOUNTING @ $2.99 for the e-book (http://booklocker.com/books/9608.html), MANAGERIAL ACCOUNTING @ $2.99 for the e-book (http://booklocker.com/books/9631.html), THE CANNABIS REPORT (weekly on http://investorshub.advfn.com/) & MARIJUANA STOCKS (http://booklocker.com/books/9045.html).
Accounting Professor teaching financial accounting; PhD, CPA, CMA, CGMA. He holds a BSBA from the University of Arizona, a Macc. from the University of Arizona, and his PhD from Virginia Tech. He worked in public accounting, industry, as a CFO, a government auditor for the California Auditor General and in litigation support. His publications have been used and filed in Court proceedings by the Securities and Exchange Commission, he has been quoted in the Wall Street Journal, and his background includes litigation support and expert testimony in cases involving business litigation (e.g., Ford, GM, and so on) in CA, AZ, TX, NV and MN. He enjoys trading stocks and securities, teaching his classes, and publishing in related areas. Also home repair and remodel, snorkling, and cruises to the Carribean.
Douglas H. Leighton
Doug is co-founder and a principal partner of Dutchess Capital, a Boston-headquartered global hedge fund, which has managed an investment portfolio of over $2 billion in transactional value. Doug oversees the fund’s risk management and facilitates all of the fund’s trading on worldwide exchanges. Doug manages deal origination in North America, Europe and Australia and is a member of the firm’s Investment Committee. Douglas has founded several companies and has mentored several startup and growth management teams. He has over two decades of experience in equity trading, investment banking, asset management and the skill set to offer advice to startups and growth companies alike. While the funds are industry agnostic, Douglas has been largely focused on the legal marijuana market for over the past 2 years, initially as an observer while he conducted due diligence for several deals, and now as an active investor and board member for several companies. He also sits on the Company Selection Committee of ArcView, the cannabis angel network as well as a member of the NCIA. Through the Fund and personally, Doug has made numerous investments in ancillary businesses to the cannabis industry, in addition to touching the plant. He is often asked to speak at conferences regarding the business side of the marijuana business. Douglas has held seats on various boards of public and private companies, in addition to serving on the boards of several non-profits.
Whether you are a large or small firm, GeoInvesting will cater to your needs and create a sound process for corporate diligence. Our specialty is Information Arbitrage: finding the hidden bits of insight that give an advantage, especially in the vast realm of microcaps that others ignore.
To accomplish this we choose to work closely with you so you can be kept abreast of the progress of our due diligence from start to finish, making sure that we cultivate a relationship of trust between our team and yours.
Who Can We Help Specifically?
We actually do not limit ourselves to any specific group. We have worked at great lengths with:
>High Net Worth Investors
>Private & Public M&A
>Other Due Diligence Firms
There is really no one that we can’t work with since we’ve covered just about every facet of the due diligence process, whether it be on-the-ground or “through the files.” We can even tailor our services to your specific requirements.
We have a retail solution for everyone – the long investor, the short investor, the pump and dump investor and the every day trader that is interested in the micro cap arena. We’ve shown that we can overcome the challenges posed by any market environment, quickly seizing investment and trading opportunities as they arise. Because of this, our Premium members have been able to enjoy above-average returns on our ideas. Our solutions enable us to cater to what matters to you the most.
Do you want access to reports that can convey the proper valuation of equities, reports that can immediately convince the market that these valuations are warranted? Do you want information arbitrage that allows you to be among the first to take action based on the intel? Do you need daily ideas, some of which have proven to be some of the most rewarding calls to action that the GeoTeam has offered? Would you like to follow our GeoBargains and select trades? Or do you just need to be part of an exclusive twitter following that receives alerts before the rest of the market?
If you have answered yes to any of the questions above, then don’t wait any longer. Join our Network and see why our following continues to grow on a daily basis. The faster you join, the more likely you will be among the first to harness the power of our offering.
Sign up today and start to get:
>Education on investing, both financial and psychological
>Access to the GeoTeam through our exclusive chatroom.
See GeoInvesting Micro Insights on Seeking Alpha Marketplace
My name is Koo Karimi from Riverside, CA.
I am here to seek and learn from the astute and be engaged in active debate about investing in stocks, particular in stock options. Please leave professional and productive commentary when discussing various articles so we can have an effective discussion regarding various investments.
It should be advised that any article material is my own opinions and ideas. Investors should conduct their own due diligence when investing in equities and various trading strategies. I am currently studying security analysis and portfolio management in preparation for the CFA.
Thank you for visiting!
I am a full-time investor. I am fairly knowledgeable about cannabis, the cannabis industry and public companies within, as a result I often like to convey my thoughts and findings. There are many companies that offer high revenue potential, but there are also many companies that are just trying to take advantage of the recent legal cannabis industry emergence. It is important, and this can be somewhat difficult, to "weed out the weeds" and pick the "good ones". I am inspired by critical thoughts, questions and presentation of new information or otherwise overlooked information.
I have been investing privately for ten years. I look to take concentrated positions in stocks with asymmetrical risk/reward profiles. Turn around situations, companies on the verge of significant revenue / EPS growth, and stocks that unjustly sell below their NCAV are all very interesting to me. I find that most of these finds come in small caps, due to their lack of coverage. However I am not averse to taking a position in a large company which I think fits one of my criteria.
Abdalla Al-ayrot is a value investor with a long time horizon. I tend to focus on misunderstood and/or under-followed companies where i believe there are a great amount of value that the market is yet to price in. Some people prefer to buy $1 for 50-60 cents, i usually buy $1 for 20-35 cents.
I have managed money for 5 years, with industry leading results, which i think is a direct result of my extensive and innovative research process.
I have also founded Ayrot, which you can read more about below.
I write, speak and give business seminars for select audiences about management, marketing and investing in growth industries with good stock buys. Consultant with startups and mid-level companies.
Former President of Sappanos Decorating Centers, Chicago, with more than 70 employees and real estate holdings in excess of $15m.
Former Research and Teaching Fellow, Harvard and Assoc. Professor Tufts Medical School.
Currently teach business and politicsin Tel Aviv, write for Seeking Alpha, the Jerusalem Post Business and Finance, and others.
I approach investing as a social theorist and a cultural historian. As a result, I am a contrarian. Studying the history of financialization, I have to agree with value investors like Seth Klarman, George Soros, and John Quiggin that markets are ultimately inefficient. However, I am not an orthodox value-investor. I believe in diversified strategy so as to insure maximum gains while maintaining a "margin of safety." Understanding that markets will operate inefficiently, I sometimes find "playing the greater fool's game" will yield nice short term gains. I have been investing for five years and have had proven results. I offer unique insight on fundamentals that most analysts do not consider.
Cornelius Vanderbilt has done more than any other man to shape our idea of investing. He was the ultimate contrarian. As an investor he looked for both value and risk. His approach to markets is complex and contradictory but can be learned from.
B.A., NYU Gallatin School
M.A. CUNY Gradatuate Center [in progress]
I started a twitter. https://twitter.com/matt_finston
Ph.D in the Faculty of Life Sciences, Bar Ilan University, Israel
Post Doctorate, Weizmann Institute of Science, Israel
Program Manager at Peerion ltd.
publisher of 14 research articles in professional journals.
Junior Staff, Instructor in Academic Courses.
studies in Economics, Israel.
Independent trader and investor over 6 years.
2 years of managing professional investors bio forum in Israel.
2 years at Aradial technologies in. Aradial Converged Billing Software - ARCB - Convergent Billing
I trade mainly on sentiment & leave the more technical aspects to other Wolves, but I do chart. I have a group of traders that pool resources & $$$ to make the #Wolf-Fund. My persona on twitter @wolfofweedstreet only discusses Marijuana related stocks.
I Am the Wolf of Weed Street and while I love profits, I hate scammy companies that trade on over hyped pr's 3x a week and Unicorn farts. I am here to bring balance to the #MMJ universe...But always do your own DD and invest wisely.